China high-tech orientation today open trading

NetEase Finance February 24 News China Hi-Tech University 23rd issued a notice, the controlling shareholder Shenzhen Kang Lung decided to hold its China high branch 24.37% of the shares, a total of 71.4937 million shares to the total price of not less than 500 million yuan transfer price transfer to the founder.　　After the transfer of the shares, Peking University has become the controlling shareholder of China Hi-tech.　　China high Tech said that after the change of interest, the founder Group of Peking University has pledged to integrate the internal assets of China Hi-tech within the next 12 months, when the relevant conditions are ripe, timing will inject the internal quality assets into the company. In the capital market, the relationship between China's hi-tech and founder Group has been "constantly cut and confused". The more typical cases include that China high has been providing guarantees to companies from 2004 onwards, including listed companies founder Technology (600601), and that the founder's guarantee is a high proportion of the total amount guaranteed by the Chinese High division. Although China's high branch does not recognize its relationship with the founder, but at that time, there are many senior Chinese high-tech executives have founder-system background. Even after the change of China's top-tech controlling shareholder to Shenzhen Kang Long in 2003, the phenomenon still exists.　　Therefore, China's hi-tech market is widely regarded as a "stealth" founder of the listed companies. At present, Fangzheng department in the A-share market has two listed companies, respectively, founder Technology and Southwest Synthesis (000788). Among them, Southwest synthesis at the end of 2010 announced will be to Beijing Beida International Hospital Group Co., Ltd. directed to issue a shares, the acquisition of its holdings of Beijing North Medical and Pharmaceutical Co., Ltd. 100% of the equity. In fact, it is another asset consolidation after the acquisition of a 90.63% stake in Chongqing Daxin Pharmaceutical Co., Ltd., which was incorporated in southwest China two years ago.　　The market had expected founder will take the Southwest synthesis as a breakthrough to promote the overall integration of its assets, including the founder of the department has inextricably linked to the Chinese high section. It is noteworthy that at the end of 2010, founder group officials have said that after several years of development, founder Group has formed it, medical medicine, real estate and financial four industries; in the next three years, founder Group will gradually transform into investment holding group. Founder of Science and Technology, Southwest synthesis has obviously become founder Group it, medical industry integration platform, and founder group Real estate business is mainly concentrated in the Beijing University Resources Group, the remaining has not yet a clear integration platform for the remaining financial industry.　　However, founder Group's most High-profile Asset founder Securities have repeatedly made clear that it will choose the IPO, so China's high-tech "return" founder system after the fate remains unclear. Secondary market, the stock trading today, trading volume is weak.